4//SEC Filing
Cramer Pamela J. 4
Accession 0001104659-25-067427
CIK 0001649904other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:30 PM ET
Size
17.0 KB
Accession
0001104659-25-067427
Insider Transaction Report
Form 4
Cramer Pamela J.
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-09$6.80/sh+10,547$71,720→ 29,756 total - Exercise/Conversion
Common Stock
2025-07-09$27.35/sh+5,025$137,434→ 34,781 total - Sale
Common Stock
2025-07-09$80.00/sh−3,516$281,280→ 19,209 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-07-09−5,025→ 15,075 totalExercise: $27.35Exp: 2033-01-31→ Common Stock (5,025 underlying) - Sale
Common Stock
2025-07-09$75.55/sh−4,225$319,217→ 30,556 total - Sale
Common Stock
2025-07-09$76.69/sh−7,831$600,565→ 22,725 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-07-09−10,547→ 17,581 totalExercise: $6.80Exp: 2032-02-08→ Common Stock (10,547 underlying)
Footnotes (5)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
- [F2]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $75.08 to $75.98 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $76.17 to $76.75 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
- [F5]The stock options were granted on February 1, 2023. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001873517
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 4:30 PM ET
- Size
- 17.0 KB